Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Tocagen Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Tocagen Inc. - Product Pipeline Review - 2014', provides an overview of the Tocagen Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Tocagen Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Tocagen Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Tocagen Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Tocagen Inc.'s pipeline products Reasons to buy - Evaluate Tocagen Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Tocagen Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Tocagen Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Tocagen Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tocagen Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Tocagen Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Tocagen Inc. Snapshot 4 Tocagen Inc. Overview 4 Key Information 4 Key Facts 4 Tocagen Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Tocagen Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Combination Treatment Modalities 9 Tocagen Inc. - Pipeline Products Glance 10 Tocagen Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 Tocagen Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Tocagen Inc. - Drug Profiles 12 vocimagene amiretrorepvec + flucytosine ER 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Toca- RNAi 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Toca-Gamma 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Tocagen Inc. - Pipeline Analysis 16 Tocagen Inc. - Pipeline Products by Target 16 Tocagen Inc. - Pipeline Products by Route of Administration 17 Tocagen Inc. - Pipeline Products by Molecule Type 18 Tocagen Inc. - Pipeline Products by Mechanism of Action 19 Tocagen Inc. - Recent Pipeline Updates 20 Tocagen Inc. - Dormant Projects 23 Tocagen Inc. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables Tocagen Inc., Key Information 4 Tocagen Inc., Key Facts 4 Tocagen Inc. - Pipeline by Indication, 2014 6 Tocagen Inc. - Pipeline by Stage of Development, 2014 7 Tocagen Inc. - Monotherapy Products in Pipeline, 2014 8 Tocagen Inc. - Combination Treatment Modalities in Pipeline, 2014 9 Tocagen Inc. - Phase I, 2014 10 Tocagen Inc. - Preclinical, 2014 11 Tocagen Inc. - Pipeline by Target, 2014 16 Tocagen Inc. - Pipeline by Route of Administration, 2014 17 Tocagen Inc. - Pipeline by Molecule Type, 2014 18 Tocagen Inc. - Pipeline Products by Mechanism of Action, 2014 19 Tocagen Inc. - Recent Pipeline Updates, 2014 20 Tocagen Inc. - Dormant Developmental Projects,2014 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.